You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / KOPRAN

KOPRAN
Intrinsic Value | Fundamental Analysis

Returns | 1W : 7.9% , 1M : 85.8%,1Y : 836.2%

BOM : 524280 NSE : KOPRAN

LT :

Long Term Analysis

Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High

Updated:

ST :

Short Term Analysis

Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%

May 14,2021

Price(EOD): Rs. 205.05

This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.

Pharmaceuticals & Drugs

MarketCap: Rs. 887.87 Cr

Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns	1W	1M	1Y
KOPRAN	7.9%	85.8%	836.2%
SUN PHARMACEUTICAL INDUSTRIES	1.7%	11.6%	51.5%
DR REDDYS LABORATORIES	0.4%	4.1%	40.6%
DIVIS LABORATORIES	-0.2%	6.3%	71.8%
CIPLA	2.4%	0.1%	57.7%
BIOCON	2.1%	-3.8%	12.2%
AUROBINDO PHARMA	-0.6%	9.9%	47.1%
LUPIN	-1.4%	12.7%	42.7%
TORRENT PHARMACEUTICALS	4.1%	6.5%	11.5%

FUNDAMENTAL ANALYSIS OF KOPRAN

Fundamentals Score

[Last Annual Data : Mar2020 | TTM

Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More

]

Show Me the Stocks with Fundamentals better than KOPRAN ^Premium

VALUATION OF KOPRAN

Valuation Score

Ratio	Consolidated
P/E P/B P/S	42.19 P/E Calculated based on EPS of 4.86 [ Mar2020 - Consolidated Results ] 4.68 P/B Calculated based on Book Value of 43.86 [ Mar2020 - Consolidated Results ] 2.02 P/S Calculated based on Revenues of 439.311 Cr [ TTM - Consolidated Results ]

Show Me the Stocks with Valuation better than KOPRAN ^Premium

FAIR VALUE OF KOPRAN

Model	Discount(-)/ Premium(+)
EV/EBIDTA EV/Sales Price/Sales	149% 150% 248%

SHARE PRICE MOMENTUM OF KOPRAN

DEBT

Year	Debt/Equity ratio
	Standalone	Consolidated
2020 2019 2018 Avg_3yrs	0.2 0.23 0.25 0.23	0.47 0.58 0.61 0.55
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares	0 %
As on : Mar2021
If less than 25%	Good
If between 25% and 50%	Neutral
If greater than 50%	Bad

QTRLY RESULTS

Consolidated	Q-o-Q	Y-o-Y
Revenue Op Profit Profit Before Tax Profit After Tax	-5.83% -0.34% -6.96% -5.53%	11.84% 73.61% 147.74% 148.8%
QtrlyTrend	0
Latest Qtr: Dec2020

KOPRAN related INDICES

No BSE index found!

No NSE index found

FAQ [Frequently Asked Questions]

Is KOPRAN good for long term investment?

As on 14-May-2021, the Fundamentals of KOPRAN are Average and hence you can wait for the results to improve to invest for long term ! See Financial Performance of KOPRAN . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is KOPRAN UnderValued or OverValued?

As on 14-May-2021, KOPRAN is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of KOPRAN ?

As on 14-May-2021, the Intrinsic Value of KOPRAN is Rs. 81.94 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 82.26
Fair Value [Median EV / Sales Model] : Rs. 81.94
Fair Value [Median Price / Sales Model] : Rs. 58.85
Median Fair Value of KOPRAN : Rs. 81.94

Is KOPRAN trading at a Premium or Discount?

As on 14-May-2021, KOPRAN is trading at a Premium of 150% based on the Median Intrinsic Value!

Is it right time to buy KOPRAN shares?

As on 14-May-2021, KOPRAN is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Financial Performance of Industry Peers of KOPRAN?

Check out Financials of Industry Peers using below links:

Financials of SUN PHARMACEUTICAL INDUSTRIES LTD
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD

Financials of AUROBINDO PHARMA LTD
Financials of LUPIN LTD
Financials of TORRENT PHARMACEUTICALS LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD

What are the Frequent Comparisons with KOPRAN?

Open Demat Account & Start Investing

Affiliate Links

Disclosure

The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].

All Stocks : A - Z

ALL A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

#15A, 4th Floor, City Vista, Tower A,
Suite No.984, Fountain Road,
Kharadi, Pune - 411014

Contact Us
support@smart-investing.in

Smart-Investing.in
Pricing Video Course

Explore
Top Gainers & Losers Quarterly Result Analysis BSE & NSE Indices

Tools
Screener Compare Analyze Portfolio

Disclaimer
The information on this site is for educational purposes only and is not investment/trading advice/research and may be delayed. We don't make any Buy/Sell recommendations and don't give any price targets. This tool provides statistical summaries of financial data in easy to understand visual form for informational purpose only. Please do your own research before making any investment decisions.

Equity investments are volatile and high risk in nature. Don't invest more than what you can afford to lose.

Financial Data Source: Accord Fintech | Methodology | Privacy Policy | Terms & Conditions |

KOPRAN Intrinsic Value | Fundamental Analysis